Diabetes Clinical Trials in San Diego

Showing 221-240 of 515 trials

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

NCT01654380

LY2605541 is an investigational drug being developed for the treatment of diabetes mellitus. This study is designed to understand how the body handles the investigational drug, what effect this investigational drug has on the body, and how much should be given. This study will also measure how much of the investigational drug gets into the blood stream and how long it takes the body to get rid of it. The study has 2 parts: Part A will be conducted in healthy participants. Part B will be conducted in participants with type 1 diabetes mellitus (T1DM). This study will take approximately 10-14 days spread over 6-20 weeks, not including screening. Screening will be performed within 30 days of the start of the study.

Healthy VolunteersDiabetes Mellitus, Type 1

Eli Lilly and Company22 participantsStarted Jul 2012

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

NCT01819129

This trial is conducted in Asia, Europe and North America. The aim of the trial is to compare FIAsp (faster-acting insulin aspart) to insulin aspart, both in combination with insulin glargine and metformin in adults with type 2 diabetes.

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S881 participantsStarted Sep 2013

Glendale, Arizona, United States • Glendale, Arizona, United States • Mesa, Arizona, United States +141 more locations

A Study of LY2605541 Versus Insulin Glargine on Blood Sugar

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Diabetes Trials in Other Cities

Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes Mellitus

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase

Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus

A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)

A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

CANVAS - CANagliflozin cardioVascular Assessment Study

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

A 24-week Open-Label, Phase 3b Trial With a 28-week Extension to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin Compared to Insulin Glargine in Subjects withType 2 Diabetes Who Have Glycemic Control on Metformin

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Other Conditions in San Diego